Windtree Therapeutics Inc Share Price Nasdaq
Equities
US97382D1054
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.99M 165M |
---|---|---|---|---|---|
Net income 2024 * | -21M -1.74B | Net income 2025 * | -29M -2.41B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.22
x | P/E ratio 2025 * |
-0.33
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.99% |
Latest transcript on Windtree Therapeutics Inc
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 01/16/01 |
Eric Curtis
COO | Chief Operating Officer | 56 | 09/20/09 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 03/21/03 |
Mark Strobeck
BRD | Director/Board Member | 53 | 22/23/22 |
Leslie Williams
BRD | Director/Board Member | 64 | 03/21/03 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |